大隐静脉反流静脉内激光消融术的长期结果：最长九年的随访。
Long-term results of endovenous laser ablation of saphenous vein reflux: Up to nine years of follow-up.
机构信息
Department of Surgery, 66984American University of Beirut Medical Center, Beirut, Lebanon.
出版信息
Phlebology. 2021 Feb;36(1):43-47. doi: 10.1177/0268355520939744. Epub 2020 Jul 13.
INTRODUCTION
Endovenous laser ablation (EVLA) has become the gold standard for the treatment of saphenous vein reflux. We report the long-term clinical and ultrasound results of EVLA.
METHODS
This study is a retrospective review of patients who underwent EVLA of saphenous vein over four years. Clinical results were assessed using venous clinical severity score (VCSS), and ultrasound results were classified according to Bush classification.
RESULTS
Over a median follow-up time of 4.4 years, 168 EVLA-treated patients showed a drop in VCSS from 4.38 to 1.39. Ultrasound results of 140 treated great saphenous veins showed that 64% had one or more cause of recurrence. The presence of neovascularization correlated well with the lack of improvement of VCSS.
CONCLUSION
EVLA resulted in drop in VCSS from 4.38 to 1.39. Among 140 treated great saphenous veins, reflux in the anterior accessory saphenous vein was the primary cause (23.5%) of recurrence.
简介
静脉内激光消融术（EVLA）已成为治疗大隐静脉反流的金标准。我们报告 EVLA 的长期临床和超声结果。
方法
本研究是对四年间接受大隐静脉 EVLA 治疗的患者进行的回顾性分析。临床结果采用静脉临床严重程度评分（VCSS）进行评估，超声结果根据 Bush 分类进行分类。
结果
在中位数为 4.4 年的随访期间，168 例接受 EVLA 治疗的患者的 VCSS 从 4.38 降至 1.39。140 条接受治疗的大隐静脉的超声结果显示，64%存在一个或多个复发原因。新生血管的存在与 VCSS 无改善密切相关。
结论
EVLA 可使 VCSS 从 4.38 降至 1.39。在 140 条接受治疗的大隐静脉中，前副隐静脉反流是复发的主要原因（23.5%）。
Zotero 插件